Loading...
Disclaimer: Informational only — not medical advice. AI hypotheses are not clinically validated. Medic Oath is for informational and educational purposes only — not medical advice. AI-generated hypotheses have not been clinically validated. Always consult a qualified healthcare professional. Privacy · Terms
A rare inherited subacute encephalopathy characterized by the variable association of basal ganglia calcification, leukodystrophy, cerebrospinal fluid (CSF) lymphocytosis and evidence of enhanced type I interferon signaling in blood and CSF.
Structure-based designed quinazoline compounds directly bind to cGAS active site (residues K173, K189, R236) preventing DNA binding and cGAMP synthesis, blocking downstream STING-IRF3-IFNB1 activation without affecting physiological DNA repair processes.
Baicalin (from TCM herb Scutellaria baicalensis) inhibits STING-TBK1-IRF3 signaling cascade while selectively blocking JAK1/TYK2 to reduce type I interferon production. Molecular targets include direct STING protein binding and downstream JAK-STAT pathway suppression.
Ultra-low dose rapamycin (0.1mg weekly) combined with bioavailable curcumin formulation enhances TFEB nuclear translocation and ULK1-Beclin1-ATG5 autophagy machinery to clear accumulated nucleic acids and damaged organelles triggering interferon responses in AGS.
Selective A2A adenosine receptor agonists (regadenoson analogs) restore SAMHD1 enzymatic balance by modulating dNTP pools and enhancing AMPK-mediated cellular energy homeostasis, reducing aberrant nucleic acid accumulation triggering innate immunity.
Glycyrrhizin and ginsenosides Rg1/Rb1 synergistically promote microglial M2 polarization through STAT6/KLF4/ARG1 pathway activation while inhibiting NF-κB p65 nuclear translocation and reducing IL-6, TNF-α, and type I interferon production in CNS.
Withanoside IV and Withanoside VI from Withania somnifera enhance mitochondrial DNA polymerase gamma (POLG) activity and upregulate OGG1, NEIL1, and PARP1 DNA repair enzymes while modulating SIRT1-PGC1α mitochondrial biogenesis pathway.